- Cloning of the first human anti-JCPyV/VP1 neutralizing monoclonal antibody: Epitope definition and implications in risk stratification of patients under natalizumab therapy2014 | Faculty of Science
- Risk stratification for progressive multifocal leukoencephalopathy in patients treated with natalizumab2012 | First Faculty of Medicine
- Viral infections and viral reactivation in immunosuppressed patients with multiple sclerosis2017 | Second Faculty of Medicine
- Opportunistic infections of the central nervous system in human immunodeficiency virus-(HIV-) infected individuals2021 | First Faculty of Medicine
- Viral infections in immunocompromised patients with hematologic malignancies.2012 | First Faculty of Medicine
- Antibodies against JC virus and stratification of the progressive multifocal leukoencephalopathy risk in patients with multiple sclerosis. Recommendations for a new diagnostic test – STRATIFY JCVTM2011 | First Faculty of Medicine
- Etiopathogenesis and diagnostics of progressive multifocal leukoencephalopathy in patients treated with natalizumab2021 | Faculty of Medicine in Hradec Králové
- A study presented at the Congress of the American Academy of Neurology in 20162016 | Faculty of Medicine in Pilsen
- Proposed MRI Safety Monitoring of Patients with Multiple Sclerosis Treated with Natalizumab2016 | First Faculty of Medicine
- Difficulties diagnosing progressive multifocal leukoencephalopathy in patients infected with the human immunodeficiency virus – case reports2013 | First Faculty of Medicine, Second Faculty of Medicine